Brief: Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine

China Regenerative Medicine International

25/01/2018 08:12

Jan 25 (Reuters) - Baolingbao Biology Co Ltd  002286.SZ : 
    * SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN 
CHINA 
REGENERATIVE MEDICINE INTERNATIONAL  8158.HK , OR 11.4 PERCENT 
STAKE, FOR HK$360 MILLION  ($46.05 million) 
 
Source text in Chinese: http://bit.ly/2Dze5gs 
Further company coverage:  002286.SZ  
 
($1 = 7.8170 Hong Kong dollars) 
 
 (Reporting by Hong Kong newsroom) 
 ((hongkong.newsroom@thomsonreuters.com; (852) 2843-6441; 
Reuters Messaging: chyenyee.lee.reuters.com@reuters.net))